Sartorius Stedim Biotech Statement on Shares and Voting Rights

Sartorius Stedim Biotech SA, based in Aubagne, has submitted an official statement regarding the composition of its share capital. As of October 31, 2024, the company announces that it has a total of 97,330,405 shares. Theoretical voting rights amount to 165,567,396, including treasury shares. However, the number of net voting rights is slightly lower, at 165,528,980 rights. This statement complies with the requirements of Article L 233-8-II of the French Commercial Code and Article 223-6 of the AMF General Regulation. This shows a stable capital structure with a slight difference between theoretical and net voting rights.